Reduction of breast tumor drug resistance by 2,3,5,4’-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect

Chemotherapy drugs have limited efficacy in breast cancer due to multidrug resistance generated by cancer cells against anticancer drugs. In this study, we developed a novel derivative, 2, 3, 5, 4‘-tetrahydroxystilbene (TG1) by modifying 2, 3, 5, 4‘-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG)....

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yao-Yuan, Lin, Hung-Jun, Hsiao, Ling-Chi, Lin, Yu-Feng, Chang, Chih-Sheng, Liu, Der-Zen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651109/
https://www.ncbi.nlm.nih.gov/pubmed/34874967
http://dx.doi.org/10.1371/journal.pone.0260533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651109/
https://www.ncbi.nlm.nih.gov/pubmed/34874967
http://dx.doi.org/10.1371/journal.pone.0260533

Ejemplares similares